Stock 1801 INNOVENT BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Innovent Biologics, Inc.

Equities

1801

KYG4818G1010

Delayed Hong Kong S.E.
Other stock markets
 01:41:26 2024-05-29 am EDT 		5-day change 1st Jan Change
35.75 HKD -2.85% Intraday chart for Innovent Biologics, Inc. -6.05% -16.49%
May. 28 Innovent Biologics, Inc. Announces Picankibart Achieved Primary Endpoints in A Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to the NDA to the NMPA CI
May. 21 Chinese Regulator Accepts Innovent Biologics' New Drug Application for Thyroid Eye Disease Drug MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. 1801 Stock
  4. News Innovent Biologics, Inc.
  5. Official Publications